Buy Xeloda (Capecitabine) Online at the Best Price

Xeloda, with its generic name capecitabine, is a chemotherapy drug used in the treatment of cancer. It falls under a class of medications known as antineoplastic agents, specifically fluoropyrimidines. Xeloda is an orally administered systemic prodrug, which means it is transformed into its active form through metabolic processes in the body. It's primarily used to treat certain types of breast, colorectal, and gastric cancers, particularly in advanced stages or when cancer has metastasized (spread to other parts of the body). Xeloda is taken orally in pill form and is often preferred for its convenience compared to traditional intravenous chemotherapy. The drug is converted into its active form in the body's tissues, where the cancer cells are present, helping to target the treatment directly to the affected areas.

What diseases does Xeloda treat?

Xeloda, or capecitabine, is primarily used in the treatment of several types of cancer. Its main applications are in:

• Colorectal Cancer: Xeloda is often used in the treatment of colorectal cancer, which affects the colon and rectum. It may be prescribed for both the initial treatment and as a part of maintenance therapy, especially in advanced stages of the disease.
• Breast Cancer: It is also employed in the treatment of breast cancer, particularly in cases where the disease has metastasized (spread to other parts of the body). Xeloda can be used as monotherapy or in combination with other chemotherapeutic agents.
• Gastric Cancer: For gastric cancer, which involves the stomach and sometimes the esophagus, Xeloda has shown efficacy, again, especially in advanced or metastatic cases.

Capecitabine may be used off-label for other types of cancer, depending on the specific clinical scenario and in accordance with a healthcare provider's judgment. The effectiveness of Xeloda is contingent on several factors, including the type and stage of cancer, the patient's overall health, and response to previous cancer treatments.

In what forms Xeloda is available?

Xeloda (capecitabine) is available in the form of oral tablets. These tablets come in different strengths to allow for dosing flexibility based on the patient's needs and treatment regimen. The common strengths of Xeloda tablets are:

• 150 mg tablets
• 500 mg tablets

The oral tablet form of Xeloda allows for convenient administration at home, which can be an advantage for patients compared to intravenous chemotherapy treatments that require clinic visits. The specific dose and schedule of Xeloda are determined by the treating physician based on various factors, including the type and stage of cancer, the patient's body surface area, general health, and response to treatment.

How to take Xeloda?

Xeloda (capecitabine) should be taken exactly as prescribed by your healthcare provider. The general guidelines for taking Xeloda are as follows:

• Dosing Schedule: The dosage and timing of Xeloda are typically based on the patient's body surface area, type and stage of cancer, and overall health. It's usually taken twice daily, about 12 hours apart.
• With Food: Xeloda should be taken within 30 minutes after finishing a meal to help reduce stomach upset.
• Swallow Whole: The tablets should be swallowed whole with water. Do not crush, split, or chew the tablets.
• Course Duration: Treatment usually consists of a series of cycles, each lasting a few weeks, with a rest period in between. Your doctor will determine the exact duration.

How long does Xeloda take to work

The time it takes for Xeloda (capecitabine) to start working can vary depending on several factors, including:

• Type of Cancer: Different cancers respond at different rates to chemotherapy.
• Stage of Cancer: Early-stage cancers might respond quicker than advanced stages.
• Individual Response: Each person's body reacts differently to chemotherapy.

Generally, some patients may see a response within a few weeks, but for others, it might take longer. Xeloda's effectiveness is often evaluated through:

• Imaging Tests: Scans like CT or MRI can show changes in tumor size or spread.
• Blood Tests: Certain markers in the blood can indicate how well the treatment is working.
• Clinical Assessment: Improvement in symptoms and overall health status.

It's important to have regular follow-ups with your healthcare provider to monitor the effectiveness of Xeloda and make any necessary adjustments to the treatment plan. Patience and adherence to the prescribed regimen are crucial, as the response to chemotherapy can be gradual.

Duration of Xeloda's Effects

The duration of Xeloda's (capecitabine's) effects in the body depends on several factors:

• Half-Life: Xeloda and its active metabolite (5-FU) have a relatively short half-life, meaning they are cleared from the body fairly quickly. The half-life of capecitabine is approximately 45 minutes, and for 5-FU, it's around 10-20 minutes.
• Treatment Regimen: The standard treatment cycle usually includes taking Xeloda for two weeks followed by a one-week rest period. This cycle is typically repeated several times.
• Individual Metabolism: How long the drug's effects last can also vary based on individual metabolic rates and overall health conditions.

It's important to note that while the drug itself is eliminated from the body relatively quickly, the effects of the medication, particularly on cancer cells, can be longer-lasting. The goal of Xeloda treatment is to cause sustained damage to cancer cells, slowing down or stopping their growth and spread.

However, the duration of clinical benefits, such as tumor shrinkage or symptom relief, will vary significantly among individuals and depends on the type and stage of cancer being treated, as well as how the cancer responds to the drug.

Regular monitoring and follow-up appointments are essential to assess the ongoing effectiveness of the treatment and make any necessary adjustments.

Is generic Xeloda available?

Generic versions of Xeloda, containing the active ingredient capecitabine, are indeed available. After the patent for the brand-name drug Xeloda expired, various manufacturers were allowed to produce and sell generic capecitabine. These generic drugs are equivalent to Xeloda in terms of dosage, safety, strength, quality, route of administration, and therapeutic use.

• Cost-Effectiveness: Generic capecitabine is generally less expensive than the brand-name drug, making it more accessible to a broader range of patients.
• Regulatory Approval: Generic capecitabine has been approved by authorities like the U.S. Food and Drug Administration (FDA), ensuring it meets the same standards as Xeloda.
• Prescription Status: Like Xeloda, generic capecitabine is available by prescription only and should be used under the guidance of a healthcare provider.
• Insurance Coverage: Coverage for generic capecitabine may vary compared to Xeloda, so it's important to check with your insurance provider.
• Consultation with Healthcare Providers: Patients are advised to consult their healthcare provider before switching to or starting generic capecitabine to ensure it is suitable for their specific condition.

Overall, the availability of generic capecitabine provides a valuable and more cost-effective option for patients requiring treatment with this chemotherapy agent.

Xeloda possible side effects

Xeloda, known generically as capecitabine, is a chemotherapy medication used in the treatment of certain types of cancer. Like all chemotherapy drugs, it can cause a range of side effects. Some common and serious side effects of Xeloda include:

Common Side Effects:

• Diarrhea: This is one of the most common side effects and can sometimes be severe.
• Nausea and Vomiting: These symptoms are also quite common but can usually be managed with anti-nausea medications.
• Hand-Foot Syndrome: Also known as palmar-plantar erythrodysesthesia, this involves redness, pain, swelling, and numbness in the hands and feet.
• Mouth Sores: Ulcers and sores in the mouth can occur, making it difficult to eat and drink.
• Loss of Appetite: Many patients experience changes in taste and a decrease in appetite.
• Fatigue: A general feeling of tiredness and lack of energy is common.

Serious Side Effects:

• Infection Risk: As with many chemotherapy drugs, Xeloda can lower white blood cell counts, increasing the risk of infection.
• Bleeding Problems: It can also reduce platelets, which help with blood clotting, leading to increased bleeding risks.
• Heart Problems: In rare cases, Xeloda can cause chest pain, heart attack, and other heart-related issues.
• Severe Diarrhea: This can lead to dehydration and electrolyte imbalances, requiring medical attention.
• Allergic Reactions: Though rare, some patients might experience allergic reactions to the medication.

It's important for patients to report any side effects to their healthcare provider, as management and intervention can be critical. Not all patients will experience all side effects, and some may experience none. The severity can also vary from person to person.

Where to buy Xeloda and how much does it cost?

Acquiring Xeloda (capecitabine) and information regarding its cost involves several factors:

Where to Buy:

• Pharmacies: Xeloda can be purchased at licensed pharmacies. A valid prescription from a healthcare provider is necessary.
• Hospital Pharmacies: Some hospital pharmacies may also dispense Xeloda, especially if the patient is receiving treatment in the hospital.
• Online Pharmacies: Accredited online pharmacies might offer Xeloda. It's crucial to ensure that the online pharmacy is reputable and requires a prescription.
• Specialty Pharmacies: Some specialized pharmacies that focus on cancer medications may stock Xeloda.

Cost of Xeloda:

• Variability: The cost of Xeloda can vary depending on factors such as geographical location, insurance coverage, and whether you're purchasing the brand-name drug or a generic version.
• Insurance Coverage: Many insurance plans cover Xeloda, but the copay amount can vary. It's advisable to check with your insurance provider.
• Generic Options: Generic versions of capecitabine are typically less expensive and may be a more affordable option.
• Assistance Programs: Some pharmaceutical companies and charitable organizations offer assistance programs to help with the cost of cancer medications.

For the most accurate and up-to-date information on where to buy Xeloda and its cost, consult with a healthcare provider or a pharmacist. They can provide guidance tailored to your specific situation, including insurance coverage and any available discounts or assistance programs.

Improvement of Quality of Life with Xeloda

Xeloda, or capecitabine, can contribute to the improvement of quality of life for patients with certain types of cancer in several ways:

Effectiveness in Cancer Treatment:

• Tumor Reduction: Xeloda has been effective in shrinking tumors, which can reduce symptoms like pain and improve overall functioning.
• Control of Disease Spread: By slowing or stopping the spread of cancer, Xeloda can help patients maintain a better level of physical activity and independence.

Convenience and Comfort:

• Oral Administration: Being an oral medication, Xeloda can be taken at home, which is more convenient and less stressful compared to intravenous chemotherapy.
• Reduced Hospital Visits: This can lead to fewer disruptions in daily life and less time spent in hospital settings.

Psychological Benefits:

• Empowerment: Oral administration allows patients to have more control over their treatment, which can be empowering and positively impact mental health.
• Reduced Anxiety: The effectiveness of Xeloda in managing cancer can reduce anxiety and stress related to the disease.

Side Effects Management:

• Manageable Side Effects: While Xeloda does have side effects, they are often manageable with the right support and medication, which helps maintain a better quality of life.

The improvement in quality of life can vary depending on the individual, the type and stage of cancer, and how the body responds to the treatment.

What other essential points are there to know about Xeloda?

The U.S. Food and Drug Administration (FDA) recently updated the decades-old approval of the chemotherapy drug capecitabine under a new initiative. This update is expected to lead to broader changes in cancer treatment. The move signifies the continuing relevance and evolution of capecitabine in oncology

The FDA has also approved new and revised indications for Xeloda. This includes its use as an adjuvant treatment for patients with Stage III colon cancer, either as a single agent or as part of a combination therapy. This expanded indication enhances the utility of Xeloda in treating various stages and types of cancer, offering new therapeutic options for patients with Stage III colon cancer.

Research has indicated that taking a low dose of Xeloda for one year after surgery to remove early-stage triple-negative breast cancer (TNBC) can reduce the risk of cancer recurrence. This finding is particularly significant because it suggests that less toxic treatment regimens, which do not include more aggressive platinum-based chemotherapy, can be effective in preventing the recurrence of this aggressive form of breast cancer.

Xeloda (capecitabine) Patient Experiences and Reviews

Excerpts from personal accounts, testimonials, and feedback from individuals who have used this medication, offering valuable perspectives on its effects, side effects, and overall impact on their health and well-being. Such information can be particularly useful for others who are considering or currently undergoing treatment with Xeloda.

One patient described Xeloda as a "wonder drug" for breast cancer metastasis to bones. They took it for 16 months and experienced stability in their condition without any significant side effects, including the common hand/foot syndrome or fatigue. They noted feeling almost normal, able to travel and work while on the medication.

Another patient, who switched from Taxol to Xeloda, appreciated the convenience of Xeloda's pill form and its slow but steady improvement in blood work results. However, they experienced pain and stiffness in the fingers, affecting their ability to type and perform daily activities, leading to a break from the medication.

A patient who had used Xeloda for over a year for stage 4 breast cancer found it easier on the body compared to IV treatments and saw good results in blood tests. They mentioned financial assistance from the drug company initially, but also expressed concerns about the financial burden after the assistance ended. While on Xeloda, they experienced more back pain and aches but were able to continue most desired activities with rest.

These personal accounts highlight the varied responses individuals can have to Xeloda, ranging from highly positive and symptom-free experiences to challenges with side effects and concerns about long-term usage and costs.